Jul.06 — Biogen Inc. and Japanese partner Eisai Co. surged after a closely watched Alzheimer’s drug showed positive results in a large clinical trial, raising hopes for treatment of a disease that’s befuddled researchers for decades. Bloomberg’s Drew Armstrong has more on “What’d You Miss?” …read more
Source:: Yahoo Finance
